Shattuck Labs, Inc. (NASDAQ:STTK – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six analysts that are presently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $7.50.
Separately, Leerink Partners started coverage on shares of Shattuck Labs in a research note on Monday. They issued an “outperform” rating and a $4.00 price objective for the company.
Check Out Our Latest Stock Analysis on Shattuck Labs
Institutional Investors Weigh In On Shattuck Labs
Shattuck Labs Price Performance
Shares of STTK stock traded up $0.05 during mid-day trading on Monday, hitting $1.24. The stock had a trading volume of 12,126 shares, compared to its average volume of 161,092. Shattuck Labs has a fifty-two week low of $0.94 and a fifty-two week high of $11.76. The firm has a market cap of $59.20 million, a PE ratio of -0.81 and a beta of 1.66. The company’s 50-day simple moving average is $1.25 and its 200-day simple moving average is $1.63.
Shattuck Labs Company Profile
Shattuck Labs, Inc, a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers.
Featured Stories
- Five stocks we like better than Shattuck Labs
- How to Capture the Benefits of Dividend Increases
- Grocery Outlet Insider and Institutional Buyers Signal Bottom
- How to trade penny stocks: A step-by-step guide
- Consumers Are Cutting Back, But These 3 Stocks Will Stay Strong
- Profitably Trade Stocks at 52-Week Highs
- Disney Stock: 4 Key Metrics Validating Its Comeback
Receive News & Ratings for Shattuck Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shattuck Labs and related companies with MarketBeat.com's FREE daily email newsletter.